Gabapentin and vigabatrin as treatment for symptomatic nystagmus in multiple sclerosis: A single blind crossover trial

被引：0
|
作者：
Bandini, F
Castello, E
Mazzella, L
Guidi, E
Mancardi, G
Solaro, C
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A29 / A30
页数：2
相关论文
共 50 条
  • [31] Multiple Sclerosis: Neurorehabilitation and Symptomatic Treatment
    Sailer, Michael
    Lindquist, Sabine
    Sickert, Almut
    Lamprecht, Juliane
    REHABILITATION, 2019, 58 (05) : 339 - 350
  • [32] Pregabalin and gabapentin in multiple sclerosis - treatment and clinical implications
    Bittner, S.
    Wiendl, H.
    Kleinschnitz, C.
    Meuth, S. G.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S474 - S475
  • [33] Open label gabapentin treatment for pain in multiple sclerosis
    Houtchens, MK
    Richert, JR
    Sami, A
    Rose, JW
    MULTIPLE SCLEROSIS JOURNAL, 1997, 3 (04) : 250 - 253
  • [34] The Symptomatic Effect of Gabapentin on Cerebellar Ataxia - A Double Blind Placebo-Controlled Trial
    Doss, Sarah
    Burmester, Linda
    Wunsch, Charlotte
    Neidel, Nadja
    Finke, Carsten
    Paul, Friedemann
    NEUROLOGY, 2016, 86
  • [35] Effects of a single oral dose of gabapentin on storm phobia in dogs: A double-blind, placebo-controlled crossover trial
    Bleuer-Elsner, Stephane
    Medam, Tiphaine
    Masson, Sylvia
    VETERINARY RECORD, 2021, 189 (07) : no
  • [36] DOUBLE-BLIND, CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN TREATMENT OF MULTIPLE-SCLEROSIS
    MERTIN, J
    KNIGHT, SC
    RUDGE, P
    THOMPSON, EJ
    HEALY, MJR
    LANCET, 1980, 2 (8201): : 949 - 951
  • [37] DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    不详
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (10): : 1387 - 1387
  • [38] Indications for symptomatic treatment of spasticity in multiple sclerosis
    Lebrun, C
    REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 1045 - 1050
  • [39] Hippotherapy in multiple sclerosis - results of a prospective, controlled, randomised and single-blind trial
    Boswell, S.
    Gusowski, K.
    Kaiser, A.
    Flachenecker, P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S264 - S264
  • [40] Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
    Green, Ari J.
    Gelfand, Jeffrey M.
    Cree, Bruce A.
    Bevan, Carolyn
    Boscardin, W. John
    Mei, Feng
    Inman, Justin
    Arnow, Sam
    Devereux, Michael
    Abounasr, Aya
    Nobuta, Hiroko
    Zhu, Alyssa
    Friessen, Matt
    Gerona, Roy
    von Budingen, Hans Christian
    Henry, Roland G.
    Hauser, Stephen L.
    Chan, Jonah R.
    LANCET, 2017, 390 (10111): : 2481 - 2489
12345